Related references
Note: Only part of the references are listed.Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
Milad Ashrafizadeh et al.
CELLULAR SIGNALLING (2021)
Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers
Asal Jalal Abadi et al.
BIOMOLECULES (2021)
Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects
Milad Ashrafizadeh et al.
LIFE SCIENCES (2021)
KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target
Yao Wei et al.
SCIENCE IMMUNOLOGY (2021)
Inhibition of SHP-1 Expands the Repertoire of Antitumor T Cells Available to Respond to Immune Checkpoint Blockade
Jeremy P. Snook et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Targeted Therapy for Non-Small Cell Lung Cancer
Zorawar S. Noor et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Versatile role of curcumin and its derivatives in lung cancer therapy
Milad Ashrafizadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Porcine CLEC12B is expressed on alveolar macrophages and blood dendritic cells
Elvira Nieto-Pelegrin et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2020)
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
David H. Peng et al.
NATURE COMMUNICATIONS (2020)
MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance
Mohammad Askandar Iqbal et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy
Mohsen Alizadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Mcl-1 Interacts with Akt to Promote Lung Cancer Progression
Guo Chen et al.
CANCER RESEARCH (2019)
C-type lectin receptors of the Dectin-1 cluster: Physiological roles and involvement in disease
Kazuya Tone et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer
Jing Li et al.
EXPERIMENTAL CELL RESEARCH (2019)
Pinpointing a potential role for CLEC12B in cancer predisposition through familial exome sequencing
Charlotte Derpoorter et al.
PEDIATRIC BLOOD & CANCER (2019)
ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling
Yongquan Huang et al.
THERANOSTICS (2019)
SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression
Liang-Zhi Wen et al.
CANCER RESEARCH (2018)
Inhibition of STAT3 in gastric cancer: role of pantoprazole as SHP-1 inducer
Jin Sung Koh et al.
CELL AND BIOSCIENCE (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma (vol 36, pg 5768, 2017)
L-C Fan et al.
ONCOGENE (2017)
Expression of C-type lectin receptor mRNA in chronic otitis media with cholesteatoma
Sang Hoon Kim et al.
ACTA OTO-LARYNGOLOGICA (2017)
SHP-1: the next checkpoint target for cancer immunotherapy?
H. Angharad Watson et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
Claudia Fumarola et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Signal Transducer and Activator of Transcription 3 as Molecular Therapy for Non-Small-Cell Lung Cancer
Cheng-Yi Wang et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Realizing the promise of cancer predisposition genes
Nazneen Rahman
NATURE (2014)
Differential proteomic analysis of caveolin-1 KO cells reveals Sh2b3 and Clec12b as novel interaction partners of caveolin-1 and Capns1 as a potential mediator of caveolin-1-induced apoptosis
Yogesh M. Kulkarni et al.
ANALYST (2013)
SHP1-mediated cell cycle redistribution inhibits radiosensitivity of non-small cell lung cancer
Rubo Cao et al.
RADIATION ONCOLOGY (2013)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
Signaling Networks Associated with AKT Activation in Non-Small Cell Lung Cancer (NSCLC): New Insights on the Role of Phosphatydil-Inositol-3 kinase
Marianna Scrima et al.
PLOS ONE (2012)
SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia
Nicola Esposito et al.
BLOOD (2011)
Src Homology Domain 2-containing Protein-tyrosine Phosphatase-1 (SHP-1) Binds and Dephosphorylates Gα-interacting, Vesicle-associated Protein (GIV)/Girdin and Attenuates the GIV-Phosphatidylinositol 3-Kinase (PI3K)-Akt Signaling Pathway
Yash Mittal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery
F. J. Rodriguez-Ubreva et al.
ONCOGENE (2010)
Identification of CLEC12B, an inhibitory receptor on myeloid cells
Sabrina C. Hoffmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Gene therapy for lung cancer
Eric M. Toloza et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades
YL Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The function of the protein tyrosine phosphatase SHP-1 in cancer
CY Wu et al.
GENE (2003)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Share Paper
